Overview
- 38 inspections across 38 sites are on record.
- 126 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-30.
At a glance
Inspections
38
Sites
38
Observations
126
Career since
Jun 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Carlsbad Technology, Inc | 30 Jun 2026 | Human Drugs | View 483 → |
| Macau-Union Pharmaceutical Limited | 17 Dec 2025 | Human Drugs | On file |
| Hovione PharmaScience Limited | 12 Dec 2025 | Human Drugs | On file |
| Shandong Jincheng Kunlun Pharmaceutical Co., Ltd. | 5 Dec 2025 | Human Drugs | On file |
| B. Braun US Pharmaceutical Manufacturing, LLC | 21 Nov 2025 | Human Drugs | View 483 → |
Sites inspected
Carlsbad Technology, IncCarlsbad, United States1 insp.
Macau-Union Pharmaceutical LimitedMacao, Macao1 insp.
Hovione PharmaScience LimitedTaipa, Macao1 insp.
Shandong Jincheng Kunlun Pharmaceutical Co., Ltd.Zibo, China1 insp.
B. Braun US Pharmaceutical Manufacturing, LLCIrvine, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Khoa Nathan V Tran6 shared
Anney Lin4 shared
Lillian S Wu4 shared
Navneet Kaur4 shared
Gloria E Andia2 shared
Pearl C Ozuruigbo2 shared
Angelica M Hernandez2 shared
Walden H Lee2 shared
Joey V Quitania2 shared
Thuy Tram L Nguyen2 shared
Full investigator report
Get the verbatim findings behind Andrew Le's 126 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site